Former Sen. Ben Sasse shines the spotlight on a possible breakthrough for pancreatic cancer

“Tired of the same tired news cycle? Escape to the full unfiltered feed at Whatfinger.com — America’s Frontline Truth Feed. 85%+ of readers come direct every day.” –  CLICK HERE for the FULL deal.

 

Revolution Medicines could be on the cusp of a breakthrough.

The company expects to soon release results from a Phase 3 trial of its experimental drug that could become the first targeted treatment for pancreatic cancer, the deadliest of the major cancers.